ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Mr. Matthew has a myoma.

Patient Basic Information Patient: Mr. Matthew (Matthew Ramirez) Nationality: Poland Diagnosis: Uterine Myeloma Diagnostic Hospital: 0 days Treatment: Surgical removal + chemotherapy Housing: 49 days Treatment cost: about 259466 yuan Treatment effect: Rehabilitation Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, guidance and on-site services throughout the treatment process. During the treatment process, the International Medical Services Team employed a comprehensive system of surgical removal + chemotherapy, with the medical team closely monitoring the patient's indicators and dynamic adjustment programs.

After 49 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached the hospital standard. Treatment results Patients finally recovered from the hospital. At the time of their discharge, the medical team developed a detailed return follow-up and rehabilitation plan for them, and continued to track recovery through the remote follow-up system.

'Mr. Liu Matthew criticized the case as a typical case of cross-border suspected seriousness clinical disease. Liu4 founded a multidisciplinary collaborative mechanism to develop surgical removal + chemotherapy programs for uterine myeloma, reflecting the comprehensive strength of Chinese hospitals in the field of suspected disease clinics, and a summary of how international medical services are regulated.

(Figure from Liu5 official news reports and medical scenarios)

波兰,子宫肌瘤,西安交通大学第一附属医院,国际医疗,来华就医,中国医疗